STAT3 and glioma: The current study has clearly shown that the novel STAT3 degrader SD‐3615 exhibits much more potent activity than Stattic in decreasing the survival of a panel of human cell lines for glioma, in apoptotic induction of these cells and in inhibiting the growth of glioma xenografts and PDXs in vivo.